adenosine monophosphate has been researched along with cariporide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harder, S; Klinkhardt, U; Kuczka, K | 1 |
Alhammouri, A; Cohen, MV; Cui, L; Downey, JM; Yang, XM | 1 |
2 other study(ies) available for adenosine monophosphate and cariporide
Article | Year |
---|---|
Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates.
Topics: Adenosine Monophosphate; Blood Platelets; Cell Aggregation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Guanidines; Humans; Leukocytes; Membrane Proteins; Neutrophil Activation; Osmosis; P-Selectin; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Hormone; Receptors, Purinergic P2Y12; Sodium-Hydrogen Exchangers; Sulfones | 2003 |
Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
Topics: Adenosine; Adenosine Monophosphate; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Guanidines; Hypothermia, Induced; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sulfones; Ticagrelor | 2013 |